New Drug to treat advanced prostate cancer

A new drug to treat advanced prostate cancer has been made by Johnson & Johnson’s called Zytiga. In the small clinical trial of six months treatment, the drug nearly eliminated tumors in about one third of men whose disease had not yet spread beyond the prostate gland but was considered likely to do so. Researchers show that bladder cancer and breast cancer patients whose tumors are eliminated before an operation